Laure Tillé

5PUBLICATIONS
56CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Tumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 31, 2026
Treatment of multiple sclerosis with peptide-coupled red blood cells induces antigen-specific T regulatory cells.

|Jun 22, 2026
The transcription factor IRF8 drives tumor-specific exhaustion in CD8+ T cells.

|Sep 14, 2023
Activation of the transcription factor NFAT5 in the tumor microenvironment enforces CD8+ T cell exhaustion.

Laure Tillé, Daniela Cropp, Mélanie Charmoy

|Jul 15, 2020
CD40 Agonist Restores the Antitumor Efficacy of Anti-PD1 Therapy in Muscle-Invasive Bladder Cancer in an IFN I/II-Mediated Manner.

Marine M Leblond, Laure Tillé, Sina Nassiri

|Apr 13, 2018
T cell-induced CSF1 promotes melanoma resistance to PD1 blockade.

Natalie J Neubert, Martina Schmittnaegel, Natacha Bordry

Pageof 1

Frequent Collaborators

2 joint publications

Grégory Verdeil

2 joint publications

Werner Held

2 joint publications

Daniela Cropp

2 joint publications

George Coukos